Delivery Order SPE2DB20D3103-SPE2DB23FP6M0
- Not listed
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $17,179.37 and has an ultimate completion date of March 7, 2024. The award was made on March 6, 2024, and there was no set-aside...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution firm. The contract has a ceiling value of $38,513.66 and an ultimate completion date of September 19, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,543.94, is a firm fixed-price delivery order awarded on December 2, 2021, with a completion date of December 3, 2021. The contract was not set aside for a specific business type. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes to the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that provides medical supplies to military treatment facilities. The $25,812.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, and does not utilize any set-aside designations. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen holds a...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,217.81 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 1, 2024 with a completion date of March 4, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $97,323.89 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a July 2024 completion date and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is a $11,132.73 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on May 20, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $18,845.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a medical product, with an ultimate completion date of October 30, 2024. This award is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category....
- This federal contract award, valued at $37,024.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a medical product, with an ultimate completion date of April 2, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,274.20, is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP6M0Delivery Order
This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,066.30 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of September 7, 2023 and was awarded on September 6, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at up to $750,000 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 9/6/23 |